期刊文献+

COPD骨骼肌萎缩患者临床特点及血清炎症因子水平研究 被引量:6

Research on clinical characteristics and inflammatory cytokines levels of patients with COPD combined with skeletal muscle atrophy
下载PDF
导出
摘要 目的研究慢性阻塞性肺疾病(COPD)合并骨骼肌萎缩患者临床特点及血清炎症因子水平。方法比较健康组、COPD非萎缩组和COPD萎缩组临床特点和血清炎症因子水平并分析相关关系。结果 COPD萎缩组患者患COPD年限长、呼吸困难评分高、运动耐力下降,体重指数、脂肪质量、脂肪指数、去脂肪质量、去脂肪指数、肺功能均下降(均P<0.01),血清TNFa及IL-8升高(均P<0.01)。血清IL-8及TNFa与运动耐力,身体组成及肺功能负相关。结论 COPD骨骼肌萎缩患者患COPD年限长,运动耐力下降,肺功能下降,身体组成发生改变。血清炎症因子TNFa及IL-8升高与COPD骨骼肌萎缩相关。 Objective To study clinical characteristics and the levels of inflammatory cytokines in patients of chronic obstructive pulmonary disease(COPD) combined with skeletal muscle atrophy.Methods The general clinical features and serum inflammatory cytokines were compared among the control group,the non-atrophic COPD group and the atrophy COPD group and the measured of the correlations were analyzed.Results COPD combined with skeletal muscle atrophy suffered a long period,with high dyspnea and a decrease of exercise tolerance.Compared to those in the control group and non-atrophic COPD group,weight,body mass index,fat mass,fat mass index,fat free mass,fat free mass index and lung functions were all significantly decreased(P0.01,for each),but serum IL-8 and TNFa significantly enhanced(P0.01,for each) in patients in the atrophy COPD group Serum IL-8 and TNFa negatively correlated with exercise tolerance,body compositions and lung functions.Conclusions Patients of COPD combined with skeletal muscle atrophy were suffered long years of COPD.Both of exercise tolerance and lung functions was reduced and body compositions were changed in these patient.The increased inflammatory serum cytokines TNFa and IL-8 are correlated with COPD combined with skeletal muscle atrophy.
出处 《临床肺科杂志》 2011年第8期1152-1154,共3页 Journal of Clinical Pulmonary Medicine
基金 川北医学院苗圃基金(MP-ZK-30)
关键词 COPD 骨骼肌萎缩 临床特点 血清炎症因子 COPD skeletal muscle atrophy clinical features inflammatory cytokines
  • 相关文献

参考文献10

  • 1Global Initiative for Chronic Obstructive Lung Disease (GOLD) IS]. 2007. Accessed March 28, 2007. Available from http:// www. goldcopd, com.
  • 2Kim HC, Mofarrahi M, Hussain SN, et al. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease[ J]. Int J Chron Obstruct Pulmon Dis,2008,3(4) :637 -658.
  • 3朱裴钦,罗勇,徐卫国.慢性阻塞性肺疾病预后因素和死亡预测因子[J].国际呼吸杂志,2007,27(4):270-273. 被引量:13
  • 4Remels AH, Sehrauwen P, Broekhuizen R, et al. Pemxisome prolif- eratoractivated receptor expression is reduced in skeletal muscle in COPD[J]. Eur Respir J,2007,30(2) :245 -52.
  • 5Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD) [ J]. Respir Med,2007,101 (9) :1954 - 1960.
  • 6Laaban JP, Kouchakji B, Dore MF, etal. Nutrition status of patients with chronic obstrtuctive disease and acute respiratory faliure [ J ]. Chest,1993,103(5) :1362 -8.
  • 7罗勇,徐卫国,董欢霁,汤庆娅.不同营养状况慢性阻塞性肺疾病患者脂群与祛脂群的比较研究[J].上海医学,2005,28(10):843-845. 被引量:7
  • 8dSchols Am. Nutrition in chronic obstructive pulmonary disease[ J]. Curt Opin Pulm Med,2000,6(2) :110 -115.
  • 9Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive pro-tein as a marker of systemic inflammation in stable chronic, Ceylan E. The value of C-reactive pro-tein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease [ J ]. Eur J Intern Med,2008,19(2) :104 - 108.
  • 10Montes de Oca M, Tortes SH, De Sanctis J, Mata A, Hernatndez N, Tdlamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD[J]. Eur Respir J,2005,26(3) :390 -397.

二级参考文献35

  • 1Bigaard J, Frederiksen K, Tjonneland A, et al. Body fat and fat free mass and all-cause mortality. Obes Res, 2004, 12:1042-1049.
  • 2Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and wemen; the health, aging and body composition study. Am J Epidemiol, 2004, 160: 741-749.
  • 3Oppert JM, Charles MA, Thibalt N, et al. Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men. Am J Clin Nutr, 2002, 75: 1107-1113.
  • 4Heitmann BL, Erikson H, Ellsinger BM, et al. Mortality associated with body fat, fat free mass and body mass index among 60-years-old swedish men a 22-years follow-up. Int J Obes Relat Metab Disord, 2000, 24: 33-37.
  • 5Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis--part 1: review of principles and methods Clin Nutr, 2004, 23: 1226-1243.
  • 6Schols AM, Slangen J, Volovics L, et al. Weight loss is amversible factor in the prognosis of chronic obstructive pulmopns ry disease. Am J Respir Crit Care Med, 1998, 157: 1791-1797.
  • 7Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.
  • 8Matheson M, Benke G, Raven J, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax, 2005,60 : 645-651.
  • 9Yeo J, Mensforth A, Karimova G, et al. Co-morbidity in the elderly with COPD-its impact on health service utilization and quality of life, a community study. Age Ageing, 2005,34 : 35.
  • 10Raguso C, Guinot S, Janssens JP, et al. Chronic hypoxia:common traits between chronic obstructive pulmonary disease and altitude. Cur Opin Clin Nutr Metab Care,2004,7:411-417.

共引文献16

同被引文献35

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部